Figures below are as of 05 Aug 2026. GMP is an unofficial, unregulated indicator of grey-market demand and is not investment advice.
| Grey Market Premium (GMP) | ₹0 |
| Issue size | ₹0.00 Cr |
| Open date | 10 Aug 2026 |
| Close date | 12 Aug 2026 |
| Listing date | 17 Aug 2026 |
| Listing at | BSE, NSE |
| IPO type | Mainboard IPO |
| Registrar | Kfin Technologies Ltd. |
As of 05 Aug 2026, the grey market premium (GMP) for the Molbio Diagnostics Ltd. IPO is ₹0. GMP is unofficial and unregulated — it indicates grey-market sentiment, not a guaranteed listing price.
The Molbio Diagnostics Ltd. IPO is open for subscription from 10 Aug 2026 to 12 Aug 2026. It is expected to list on 17 Aug 2026.